Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04JAX
|
||||
| Former ID |
DNC013818
|
||||
| Drug Name |
6-Methyl-4-(4-o-tolylpiperazin-1-yl)coumarin
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529641] | ||
| Formula |
C21H22N2O2
|
||||
| Canonical SMILES |
CC1=CC2=C(C=C1)OC(=O)C=C2N3CCN(CC3)C4=CC=CC=C4C
|
||||
| InChI |
1S/C21H22N2O2/c1-15-7-8-20-17(13-15)19(14-21(24)25-20)23-11-9-22(10-12-23)18-6-4-3-5-16(18)2/h3-8,13-14H,9-12H2,1-2H3
|
||||
| InChIKey |
WISLSRMHRCKWLA-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Acetylcholinesterase | Target Info | Inhibitor | [529641] | |
| KEGG Pathway | Glycerophospholipid metabolism | ||||
| Cholinergic synapse | |||||
| Pathway Interaction Database | ATF-2 transcription factor network | ||||
| PathWhiz Pathway | Phospholipid Biosynthesis | ||||
| References | |||||